Leuven -TiGenix is pleased to announce that ChondroCelect®, its cell based medicinal product for cartilage repair in the knee, will be available and reimbursed for hospital use in Belgium with effect from May 1st 2011.
131183
ChondroCelect® available and reimbursed in Belgium
63912
Breakthrough could nip arthritis in the bud
150609
The global spinal surgical market is projected to reach almost $6.5 billion by 2015
132778
Cellectricon settles patent infringement litigation with Fluxion
52206
Medtronic to offer Prostiva prostate treatment from Urologix
106500
Igesund admitted to hospital
152718
Nelson hyperextends surgically repaired knee
67623
Skin cells converted into blood
59485
Consortium supports next generation drug discovery
51501
ZymoGenetics offering $79 million in common stock
41935
Topical anesthetic cream for relieving pain
41981
Schilens visits knee specialist
175596
Compugen discovers cancer treatment target
151825
Toward stem cell pharmacies
28106
Incyte says psoriasis drug meets main goal
65487
Amgen selling Japanese rights to some drugs
26140
ClearKone® prescribed to more than 16,000 patients in 32 countries